Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Vector Science & Therapeutics Corp., LyoGenesis Plus, and Wynn Pharmaceuticals Partner to Develop IV Bag and Vial Adaptor Products.

Jul 28, 2026•12 days ago

Contract Type

partnership

DelawareBiotechnology

Description

Vector Science & Therapeutics Corp., LyoGenesis Plus, and Wynn Pharmaceuticals have entered into a Memorandum of Understanding to collaborate on new IV bag and vial adaptor products. This partnership aims for significant revenue generation, with expectations of scaling to $64 million in annual revenue over five years.

Company Information

Company

Vector Science & Therapeutics

Location

Delaware, United States

About

Vector Science & Therapeutics Corp. is an early-stage biotechnology company focused on developing and manufacturing pharma-grade peptides. They are advancing several innovative verticals aimed at driving revenue and profitability. The company operates under FDA license and adheres to cGMP standards for its manufacturing processes.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Vector Science & Therapeutics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.